Principal Financial Group
TBIO

Principal Financial Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Principal Financial Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,430
Closed -$728K – 2645
2021
Q2 		$728K Sell
26,430
-4,601
-15% -$90.4K ﹤0.01% 2118
2021
Q1 		$512K Sell
31,031
-1,559
-5% -$35.5K ﹤0.01% 2145
2020
Q4 		$601K Buy
32,590
+22,305
+217% +$399K ﹤0.01% 2072
2020
Q3 		$140K Buy
+10,285
New +$159K ﹤0.01% 2244

Principal Financial Group's TBIO Position: Q3 2021 in Review

Principal Financial Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 26,430 shares — an estimated $728K sold.

Principal Financial Group first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $728K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Principal Financial Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Principal Financial Group sold 26,430 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $728K.
  • Principal Financial Group first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Principal Financial Group's Translate Bio, Inc. Common Stock position peaked at $728K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Principal Financial Group's 13F filing for Q3 2021, filed 9 Nov 2021.